CIM Investment Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,546
Closed -$818K 260
2024
Q2
$818K Sell
2,546
-25
-1% -$8.12K 0.25% 80
2024
Q1
$858K Hold
2,571
0.26% 74
2023
Q4
$696K Hold
2,571
0.22% 93
2023
Q3
$632K Sell
2,571
-54
-2% -$14.8K 0.23% 93
2023
Q2
$797K Buy
2,625
+5
+0.2% +$1.39K 0.27% 75
2023
Q1
$691K Buy
2,620
+113
+5% +$28.7K 0.26% 89
2022
Q4
$602K Sell
2,507
-65
-3% -$14.6K 0.24% 93
2022
Q3
$473K Hold
2,572
0.21% 107
2022
Q2
$432K Sell
2,572
-12
-0.5% -$2.58K 0.18% 122
2022
Q1
$648K Sell
2,584
-3
-0.1% -$753 0.22% 97
2021
Q4
$665K Sell
2,587
-42
-2% -$10.3K 0.2% 105
2021
Q3
$638K Buy
+2,629
New +$643K 0.2% 104

Other funds holding HCA

CIM Investment Management's HCA Position: Q3 2024 in Review

CIM Investment Management sold out of HCA Healthcare (HCA) in Q3 2024, closing a stake of 2,546 shares — an estimated $818K sold.

CIM Investment Management first reported a position in HCA in Q3 2021 and held it in 12 quarters. The position peaked at $858K in Q1 2024. 1,202 funds tracked by Wall St. Rank hold HCA as of Q3 2024.

  • CIM Investment Management reported no remaining HCA Healthcare position as of Q3 2024 after selling out during the quarter.
  • CIM Investment Management sold 2,546 HCA Healthcare shares in Q3 2024, an estimated $818K.
  • CIM Investment Management first reported a position in HCA Healthcare in Q3 2021 and held it in 12 quarters.
  • CIM Investment Management's HCA Healthcare position peaked at $858K in Q1 2024.
  • 1,202 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2024.

Based on CIM Investment Management's 13F filing for Q3 2024, filed 25 Nov 2024.